Invion Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,952.50
2,309.40
437.40
917.50
2,891.40
Total Accounts Receivable
662.20
1,893.30
647.50
32.30
91.80
Other Current Assets
141.80
133.80
81.80
57.00
77.60
Total Current Assets
4,756.60
4,336.50
1,166.70
1,006.90
3,060.80
Net Property, Plant & Equipment
29.00
26.70
5.80
2.60
-
Total Investments and Advances
67.40
52.10
53.90
-
-
Intangible Assets
9,877.70
11,683.90
10,755.60
4,802.50
7,288.30
Total Assets
14,730.60
16,099.30
11,982.00
5,812.00
10,349.00
ST Debt & Current Portion LT Debt
15.90
2,578.70
120.20
1,257.10
20.30
Accounts Payable
527.40
1,705.10
204.70
117.40
567.80
Other Current Liabilities
248.80
430.50
312.70
430.30
1,193.50
Total Current Liabilities
792.20
4,714.30
637.60
1,804.80
1,781.70
Long-Term Debt
2,486.70
2,486.70
3,686.70
2,486.70
2,486.70
Provision for Risks & Charges
15.10
18.10
-
-
8.50
Deferred Taxes
3,764.30
4,506.80
4,155.40
-
652.50
Total Liabilities
7,058.30
11,725.80
8,479.70
4,291.50
4,929.40
Common Equity (Total)
7,672.40
4,373.50
3,502.30
1,520.50
5,419.60
Total Shareholders' Equity
7,672.40
4,373.50
3,502.30
1,520.50
5,419.60
Total Equity
7,672.40
4,373.50
3,502.30
1,520.50
5,419.60
Liabilities & Shareholders' Equity
14,730.60
16,099.30
11,982.00
5,812.00
10,349.00

About Invion

View Profile
Address
722 High Street
Melbourne Victoria (VIC) 3102
Australia
Employees -
Website http://www.inviongroup.com
Updated 07/08/2019
Invion Ltd. engages in the development of treatments for respiratory and autoimmune disease. It develops the following drug assets: nadolol, zafirlukast, and ala-Cpn10. The company was founded on October 11, 2000 and is headquartered in Chermside, Australia.